Уноси

• Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses (2013)

  B. Mirjanic-Azaric, M. Rizzo, L. Sormaz, D. Stojanovic, S. Uletilović, S. Sodin-Semrl, K. Lakota, A. Artenjak, J. Marc, D. Cerne, Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses, CLINICAL BIOCHEMISTRY, Vol. 46, pp. 1526 - 1531, 2013

• Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients. (2014)

  B. Mirjanic-Azaric, J. Vekic, A. Zeljkovic, Z. Jelic-Ivanovic, M. Djeric, T. Milivojac, U. Pecar Fonovic, J. Marc, J. Kos, D. Cerne, Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients., JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, Vol. 21, pp. 868 - 877, 2014

• Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA. (2015)

  B. Mirjanic-Azaric, Z. Jelic-Ivanovic, A. Zeljkovic, J. Vekic, G. Jurgens, T. Milivojac, S. Avram, J. Coric, J. Marc, D. Cerne, Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA., JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 34, pp. 314 - 322, 2015

• Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients. (2015)

  B. Mirjanic-Azaric, M. Rizzo, G. Jurgens, S. Hallstroem, s. Srdic, J. Marc, D. Cerne, Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients., SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, Vol. 75, pp. 382 - 389, 2015